Pegylated bovine carboxyhemoglobin

N/A

Report date: 2026/05/08 20:02:52

Base Information

Drug NamePegylated bovine carboxyhemoglobin
Drug Alias Name聚乙二醇牛碳氧血红蛋白SanguinatePEG-HbPEG-LEHPEG-bHb-CO +[6] 
ClassificationBiologics > Protein drugsBiologics > Blood components
Mechanisms of ActionOxygen carriers
TargetsNot applicable
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsHypoxiaDelayed Graft Function +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPanamaUnited StatesHonduras +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnzon Pharmaceuticals IncRutgers University
China Registration ClassN/A

Develop Information

Active CompaniesEnzon Pharmaceuticals IncProlong Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsHypoxiaDelayed Graft FunctionThalassemia +[5] 
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsLeg UlcerAnemia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A